Stage Iiib Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Stage Iiib Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative [Phase 2, Phase 3]
A phase 2/3 trial evaluating the addition of radiation therapy to standard immunotherapy with or without chemotherapy for PD-L1–negative adv…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer [Phase 3]
Phase 3 clinical trial update describing a study comparing treatment given before versus after surgery in patients with resectable stage II …
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Peripheral Blood ETASTs for Predicting Efficacy of Chemoimmunotherapy in NSCLC
A clinical trial to evaluate whether peripheral blood ETASTs can predict the efficacy of chemoimmunotherapy in non-small cell lung cancer. T…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Neoadjuvant SBRT Followed by Sintilimab Plus Chemotherapy for N3-Positive NSCLC [Phase 2]
This is a Phase 2 neoadjuvant trial of SBRT followed by sintilimab plus chemotherapy for N3-positive locally advanced non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB, IIIA, and Select IIIB and IIIC Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating MRI-guided adaptive radiation therapy with concurrent chemotherapy and consolidation durvalumab in inoperable Stage…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery [Phase 2]
This Phase 2 clinical trial update reports results for a hypofractionated boost before chemoradiation in patients with stage II–III non-smal…
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO) [Phase 2]
This document reports a Phase 2 clinical trial update examining atezolizumab in combination with induction chemotherapy and radiotherapy for…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Evaluating Modifiable Biomarkers for the Prediction of Immunotherapy Response and Toxicity
A completed clinical trial evaluating modifiable biomarkers to predict immunotherapy response and toxicity in non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2025-01-21Clinical Trial Update: Efficacy and Safety of Ensartinib in Neoadjuvant Therapy for Stage IIA - IIIB (Operable or Potentially Operable) ALK-Positive Lung Adenocarcinoma ：A Multicenter, Real-World Clinical Study [Phase 4]
Phase 4 multicenter real-world study evaluating the efficacy and safety of ensartinib as neoadjuvant therapy for stage IIA-IIIB ALK-positive…
-
CLINICAL_TRIALS trial_result · 2024-03-04Clinical Trial Update: FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial of FR901228 in patients with refractory or progressive small cell lung cancer or non-small cell lung cancer has compl…
-
CLINICAL_TRIALS trial_result · 2023-12-06Clinical Trial Update: Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma [Phase 1]
Phase 1 trial assessing trigriluzole in combination with nivolumab and pembrolizumab for various metastatic or unresectable solid tumors and…
-
CLINICAL_TRIALS trial_result · 2020-06-23Clinical Trial Update: Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial assessing whether adding metformin hydrochloride to chemotherapy and radiation improves outcomes for Stage III non-small cel…
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: 18F-FSPG PET/CT for Cancer Patients on Therapy [Phase 2]
Phase 2 clinical trial update on 18F-FSPG PET/CT for cancer patients undergoing therapy; study status completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by Surgery [NA]
The Wake Forest University Health Sciences trial NCT02566421, evaluating genomic sequencing to guide treatment for metastatic, recurrent, or…
-
CLINICAL_TRIALS trial_result · 2017-02-02Clinical Trial Update: Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy [Phase 3]
Phase 3 trial investigating sunitinib malate as maintenance therapy after chemotherapy in stage IIIB/IV non-small cell lung cancer; study co…
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial results evaluating the combination of chemotherapy, radiation therapy, and bevacizumab in newly diagnosed, unresectable stage …
-
CLINICAL_TRIALS trial_result · 2015-11-18Clinical Trial Update: RO4929097 in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Recently Completed Treatment With Front-Line Chemotherapy [Phase 2]
Phase 2 trial of RO4929097 in advanced non-small cell lung cancer patients recently treated with front-line chemotherapy; the study was term…
-
CLINICAL_TRIALS trial_result · 2015-09-14Clinical Trial Update: S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
This Phase 2 clinical trial (S0536) evaluated the combination of cetuximab, paclitaxel, carboplatin, and bevacizumab in patients with advanc…
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: E7389 in Treating Patients With Recurrent or Progressive Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial of eribulin mesylate (E7389) in recurrent or stage IIIB/IV non-small cell lung cancer has completed, and results were posted.
-
CLINICAL_TRIALS trial_result · 2014-10-10Clinical Trial Update: Celecoxib and Erlotinib in Treating Former Smokers With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating the combination of celecoxib and erlotinib in former smokers with stage IIIB or stage IV non-small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2014-03-07Clinical Trial Update: Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer [Phase 2]
Phase II trial assessing carboplatin plus gemcitabine in patients with Stage IIIB non-small cell lung cancer and Stage IV non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2013-06-28Clinical Trial Update: Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluated a combination of docetaxel, cisplatin, pegfilgrastim, and erlotinib in patients with stage IIIB or stage IV non-sm…
-
CLINICAL_TRIALS trial_result · 2013-06-06Clinical Trial Update: Erlotinib and Celecoxib in Treating Patients With Stage IIIB or Stage IV Recurrent Non-Small Cell Lung Cancer [Phase 2]
This is a completed Phase 2 trial update evaluating Erlotinib in combination with Celecoxib for patients with Stage IIIB or Stage IV recurre…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluated first-line therapy with docetaxel plus cetuximab or docetaxel plus bortezomib in patients with Stage IIIB or Stage…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Suramin, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating the combination of suramin, paclitaxel, and carboplatin in patients with stage IIIB or stage IV non-small cell lung…